The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice.
D000666:Amphotericin B / Q000627:therapeutic use*; D000818:Animals; D004359:Drug Therapy, Combination; D007654:Ketoconazole / Q000627:therapeutic use*; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012293:Rifampin / Q000627:therapeutic use*
D000666:Amphotericin B; D007654:Ketoconazole; D012293:Rifampin